The Quadram Institute is an interdisciplinary research centre capitalising on the academic excellence and clinical expertise of the Norwich Research Park. Its mission is to understand how food and the gut microbiota link to the promotion of health and the prevention of diet and age-related diseases. It brings together fundamental and translational science with a clinical research facility for human trials and one of Europe’s largest gastrointestinal endoscopy units. The Quadram Institute is accelerating innovation by synergising interactions between basic and clinical research, delivering a step-change in the understanding of the role of food and the microbiome on health.
Queen May Innovation Ltd (QMI), is the wholly owned technology transfer subsidiary of Queen Mary, University of London. QMI is responsible for identifying, protecting and commercialising novel technologies in medicine and dentistry, healthcare, science and engineering. QMI manages a large and varied portfolio of licensed technologies and spin-out companies. With around 16,900 students, 3800 staff and an annual turnover of £300m, we are one of the biggest University of London colleges. The London School of Medicine and Dentistry faculty focuses on: translational research, cancer, cardiac, dentistry, inflammation, endocrinology/metabolism, immunology and infectious diseases, genomics, neuroscience, gastroenterology, epidemiology and primary care.
The Business Development Office provides access to Queen Mary University of London cutting-edge capabilities and state-of–the-art facilities. Our team of Business Development Managers will identify relevant academic expertise to meet your commercial requirements through collaborative research, contract research and consultancy.
Queen’s House Consulting is an independent pharmaceutical and healthcare consultancy, supporting the biological/biotech and healthcare sectors to develop ideas into commercial products. This draws on decades of successful real-world experience to help founders, growing companies and investors achieve their goals for bio/pharmaceutical & (ultra)orphan drug strategy, product development, lifecycle management and healthcare delivery.
Queen's House Consulting recognises that clients have different priorities for consultancy services as they evolve from pre-seed start-up to Series A/B maturity and beyond. After initial discussions, each proposal is tailored to meet your individual needs and budgets. To strengthen your business programme, start the conversation in person at One Nucleus events or message [email protected] .
Queen's House Consulting recognises that clients have different priorities for consultancy services as they evolve from pre-seed start-up to Series A/B maturity and beyond. After initial discussions, each proposal is tailored to meet your individual needs and budgets. To strengthen your business programme, start the conversation in person at One Nucleus events or message [email protected] .
With trusted scientific insight brought to every program and 35+ years of ensuring quality & control throughout the development process, Quotient Sciences is a drug development & manufacturing accelerator helping clients bring molecules to cures, fast.
Services for drug productspan from early phase to late-stage and commercial, and our clinical pharmacology services are focused on early phase, with a full suite of drug productspan from early phase to late-stage and commercial, and our Phase I studies from first-in-human (FIH), single and multiple ascending dose (SAD / MAD) to regulatory and exploratory clinical studies including human ADME , TQT, DDI , and bioavailability studies.
We pioneered the integration of CRDMO services to create Translational Pharmaceutics® —a unique and disruptive platform that integrates drug product manufacturing & clinical testing for better clinical outcomes, reduced costs & timeline acceleration by up to 12 months.
Links:
Quotient - https://shorturl.at/tB7i6
Drug product - https://shorturl.at/LE4Rb
Clinical pharmacology services - https://shorturl.at/mUyaD
Phase 1 - https://tinyurl.com/yc7jwh7s
First in-human - https://tinyurl.com/54rudeny
Human ADME - https://tinyurl.com/y7dprjrz
DDI - https://tinyurl.com/su2xw37a
CRDMO - https://tinyurl.com/4naz89ex
Translational Pharmaceutics - https://tinyurl.com/2p9vz7j9
Drug product manufacturing - https://tinyurl.com/3t3m6rch
Clinical testing: https://tinyurl.com/bp9dpps9
Services for drug productspan from early phase to late-stage and commercial, and our clinical pharmacology services are focused on early phase, with a full suite of drug productspan from early phase to late-stage and commercial, and our Phase I studies from first-in-human (FIH), single and multiple ascending dose (SAD / MAD) to regulatory and exploratory clinical studies including human ADME , TQT, DDI , and bioavailability studies.
We pioneered the integration of CRDMO services to create Translational Pharmaceutics® —a unique and disruptive platform that integrates drug product manufacturing & clinical testing for better clinical outcomes, reduced costs & timeline acceleration by up to 12 months.
Links:
Quotient - https://shorturl.at/tB7i6
Drug product - https://shorturl.at/LE4Rb
Clinical pharmacology services - https://shorturl.at/mUyaD
Phase 1 - https://tinyurl.com/yc7jwh7s
First in-human - https://tinyurl.com/54rudeny
Human ADME - https://tinyurl.com/y7dprjrz
DDI - https://tinyurl.com/su2xw37a
CRDMO - https://tinyurl.com/4naz89ex
Translational Pharmaceutics - https://tinyurl.com/2p9vz7j9
Drug product manufacturing - https://tinyurl.com/3t3m6rch
Clinical testing: https://tinyurl.com/bp9dpps9
No data available
In the early 1960s REED pioneered specialist recruitment services, a move which fundamentally changed the UK recruitment market. Today, with over 30 specialist recruitment divisions, the provision of temporary and permanent staff remains a core focus for REED.. . Reed Scientific specialised in supporting the Biotechnology, Chemicals, Food Technology, Pharmaceutical and Clinical markets. With 4 regional offices, Reed Scientific have the strength of a local presence coupled to an international support structure that allows them to fill permanent, temporary and interim vacancies with high calibre candidates.. . Our mission is to be the world's best recruiter, through constant innovation and continuous improvement.. . We will achieve our mission by living our values each day and working as one company, with global ambition:. . We are fair, open and honest -. We treat everyone with fairness and respect We act with integrity We are true to our commitments. . We take ownership -. We respond swiftly to execute our promises We take responsibility for providing solutions We hold ourselves accountable for our actions. . We work together -. We work in partnership and build sustainable trust relationships We value a diverse workforce and respect the contributions of all We support our customers and colleagues in achieving their goals.
We are regenold: a regulatory and development services partner for pharmaceutical, biotech, medtech, IVD, and combination product developers. We support the full product lifecycle, from early development through to approval and beyond. Working from our own offices across Europe and through regulanet®, our global network of specialists in more than 90 countries, we help clients navigate complex regulatory environments and bring healthcare solutions to patients.
Resolian is a global contract research organization (CRO) supporting pharmaceutical and biotech companies with specialized bioanalytical and analytical sciences solutions. Over 500 experts across the U.S., U.K., China, and Australia deliver quality results, ensuring the highest standard of regulatory compliance throughout the drug development continuum.
Resolian’s specialized solutions include small and large molecule LC-MS/MS bioanalysis, PK immunoassays for large molecules, immunogenicity, biomarkers, cell-based assays, drug metabolism/pharmacokinetics (DMPK), and CMC analytical and materials science. Dedicated laboratories equipped with state-of-the-art technology meet the needs of preclinical and clinical programs at any scale.
For more information please see https://www.linkedin.com/company/resolian/home/
Resolian’s specialized solutions include small and large molecule LC-MS/MS bioanalysis, PK immunoassays for large molecules, immunogenicity, biomarkers, cell-based assays, drug metabolism/pharmacokinetics (DMPK), and CMC analytical and materials science. Dedicated laboratories equipped with state-of-the-art technology meet the needs of preclinical and clinical programs at any scale.
For more information please see https://www.linkedin.com/company/resolian/home/
Riverlabs is a new and exciting 28-acre life sciences campus, ideally situated at the centre of the ‘Golden Triangle’ in Ware, Hertfordshire. 440,000 sq ft (GIA) will be available in three phases:
• The most affordable, existing, purpose-built R&D space in the ‘Golden Triangle’. An intelligent refresh will transform existing labs into a modern, welcoming and sustainable working environment with staff wellbeing at its heart.
• Available for fit-out in January 2023, Riverlabs 1 provides 141,423 sq ft (GIA) of ready-built, affordable, wet laboratory and write-up space.
• Available for fit-out in May 2023, Riverlabs 2 provides 219,900 sq ft (GIA) of ready-built, affordable, wet laboratory and write-up space.
• Set within a unique, open campus environment enjoying natural waterfront to the River Lea. 15 acres of open green space plus sports club, tennis courts, cricket pitch, five-a-side football, access to water-based activities, river walks and nature on the doorstep.
• Perfectly positioned in an established life sciences ecosystem. Home to GSK for 50+ years, and within a 45-minute radius of major life science clusters in London, Cambridge and Stevenage, providing a huge pool of life sciences talent to recruit from.
To find out more visit https://www.riverlabsware.com
• The most affordable, existing, purpose-built R&D space in the ‘Golden Triangle’. An intelligent refresh will transform existing labs into a modern, welcoming and sustainable working environment with staff wellbeing at its heart.
• Available for fit-out in January 2023, Riverlabs 1 provides 141,423 sq ft (GIA) of ready-built, affordable, wet laboratory and write-up space.
• Available for fit-out in May 2023, Riverlabs 2 provides 219,900 sq ft (GIA) of ready-built, affordable, wet laboratory and write-up space.
• Set within a unique, open campus environment enjoying natural waterfront to the River Lea. 15 acres of open green space plus sports club, tennis courts, cricket pitch, five-a-side football, access to water-based activities, river walks and nature on the doorstep.
• Perfectly positioned in an established life sciences ecosystem. Home to GSK for 50+ years, and within a 45-minute radius of major life science clusters in London, Cambridge and Stevenage, providing a huge pool of life sciences talent to recruit from.
To find out more visit https://www.riverlabsware.com